Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking

Insiya Z. Mukadam, Jatin Machhi, Jonathan Herskovitz, Mahmudul Hasan, Maxim D. Oleynikov, Wilson R. Blomberg, Denis Svechkarev, Aaron M. Mohs, You Zhou, Prasanta Dash, Jo Ellyn McMillan, Santhi Gorantla, Jered Garrison, Howard E. Gendelman, Bhavesh D. Kevadiya

Research output: Contribution to journalArticle

Original languageEnglish (US)
Article number119669
JournalBiomaterials
Volume231
DOIs
StatePublished - Feb 2020

Keywords

  • Aggregation-induced emission
  • Antiretroviral therapy
  • CD4 T cell tracking
  • Drug biodistribution
  • Monocyte-macrophage
  • Rilpivirine
  • Single-crystal x-ray diffraction

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Mukadam, I. Z., Machhi, J., Herskovitz, J., Hasan, M., Oleynikov, M. D., Blomberg, W. R., Svechkarev, D., Mohs, A. M., Zhou, Y., Dash, P., McMillan, J. E., Gorantla, S., Garrison, J., Gendelman, H. E., & Kevadiya, B. D. (2020). Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking. Biomaterials, 231, [119669]. https://doi.org/10.1016/j.biomaterials.2019.119669